What does CUSIP 28617K101 represent in this 13F holders report?

CUSIP 28617K101 is the security identifier for ELDN - Eledon Pharmaceuticals, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held ELDN - Eledon Pharmaceuticals, Inc. - Common Stock in Q1 2024?

28 institutional investors reported ELDN - Eledon Pharmaceuticals, Inc. - Common Stock for Q1 2024. Use the holders table for investor-level position and value details.

Eledon Pharmaceuticals, Inc. - Common Stock (ELDN)

CUSIP: 28617K101

Q1 2024 13F Holders as of 31 Mar 2024

Security type / class: Equity / Common Stock
Total 13F shares: 9,595,061
Total 13F value: $19,765,324
Share change: +441,893
Put/Call ratio: 280%
SEC-reported price per share: $2.06
Number of holders: 28
Value change: +$914,973
Number of buys: 11
Number of sells: 10
Shares outstanding: 81,270,267

Security key

28617K101

Report period

Q1 2024

Institutions

Top holders

ELDN full security history Ownership snapshot Full 13F holder table Eledon Pharmaceuticals, Inc. SEC filings Eledon Pharmaceuticals, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of ELDN - Eledon Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

BVF INC/IL

Disclosed value leader

BVF INC/IL

Comparable rows

0/15

Latest evidence

31 Dec 2023

13F 3/4/5 Highest disclosed value: $7,788,078 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

BVF INC/IL has the largest disclosed position value at $7.79M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BVF INC/IL's linked filing trail.

Disclosed position value Top 5

BVF INC/IL $7.79M

ARMISTICE CAPITAL, LLC $3.94M

VANGUARD GROUP INC $1.25M

Woodline Partners LP $1.24M

Ensign Peak Advisors, Inc $797.4K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
BVF INC/IL	13F Company 13F	— denominator unverified	$7,788,078 4,326,710 shares	—	31 Dec 2023
ARMISTICE CAPITAL, LLC	13F Company 13F	— denominator unverified	$3,940,200 2,189,000 shares	—	31 Dec 2023
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$1,251,752 695,418 shares	—	31 Dec 2023
Woodline Partners LP	13F Company 13F	— denominator unverified	$1,240,812 689,340 shares	—	31 Dec 2023
Ensign Peak Advisors, Inc	13F Company 13F	— denominator unverified	$797,402 443,001 shares	—	31 Dec 2023
Gary A. Lyons	3/4/5 Director 3/4/5	— denominator unverified	$673,958 150,437 shares	—	01 May 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

9,595,061

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q1 2024 Across Filers

Q1 2024 holders

Holder diff

Investor	Q1 2024 Shares	Q1 2024 Shares	Share Diff	Share Chg %	Q1 2024 value	Q1 2024 value	Value change	Value Chg %